FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martine Roussel

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Daisuke Kawauchi; Stanley Pounds; Chunxu Qu; Jerold Rehg; Giles Robinson; David W Ellison; David Finkelstein; Cuilan Gao; Paul Gibson; Richard J Gilbertson; Tamar Uziel; Martine F Roussel
A mouse model of the most aggressive subgroup of human medulloblastoma.
Sara Gil-Perotin; Jeffery D Haines; Jasbir Kaur; Kwi-Hye Kim; Mireya Marin-Husstege; Martine F Roussel; Timothy Schallert; Michael J Spinetta; Frederique Zindy; Maria Duran-Moreno; Jose Manuel Garcia-Verdugo; Patrizia Casaccia
Roles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zone.
Yuefeng Wang; John C Fisher; Rose Mathew; Li Ou; Steve Otieno; Jack Sublet; Limin Xiao; Jianhan Chen; Martine F Roussel; Richard W Kriwacki
Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martine Roussel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Daisuke Kawauchi; Stanley Pounds; Chunxu Qu; Jerold Rehg; Giles Robinson; David W Ellison; David Finkelstein; Cuilan Gao; Paul Gibson; Richard J Gilbertson; Tamar Uziel; Martine F Roussel
A mouse model of the most aggressive subgroup of human medulloblastoma.
Cancer cell 2012;21(2):168-80.
2011: Sara Gil-Perotin; Jeffery D Haines; Jasbir Kaur; Kwi-Hye Kim; Mireya Marin-Husstege; Martine F Roussel; Timothy Schallert; Michael J Spinetta; Frederique Zindy; Maria Duran-Moreno; Jose Manuel Garcia-Verdugo; Patrizia Casaccia
Roles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zone.
The European journal of neuroscience 2011;34(7):1040-52.
2011: Yuefeng Wang; John C Fisher; Rose Mathew; Li Ou; Steve Otieno; Jack Sublet; Limin Xiao; Jianhan Chen; Martine F Roussel; Richard W Kriwacki
Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21.
Nature chemical biology 2011;7(4):214-21.
2011: Martine F Roussel; Mary E Hatten
Cerebellum development and medulloblastoma.
Current topics in developmental biology 2011;94():235-82.
2010: Martine F Roussel
New concepts in organ site research on medulloblastoma: genetics and genomics.
Future oncology (London, England) 2010;6(8):1229-31.
2010: Olivier Ayrault; Haotian Zhao; Frederique Zindy; Chunxu Qu; Charles J Sherr; Martine F Roussel
Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells.
Cancer research 2010;70(13):5618-27.
2009: Olivier Ayrault; Michael D Godeny; Christopher Dillon; Frederique Zindy; Patrick Fitzgerald; Martine F Roussel; Helen M Beere
Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(40):17037-42.
2009: Danny T Huang; Olivier Ayrault; Harold W Hunt; Asad M Taherbhoy; David M Duda; Daniel C Scott; Laura A Borg; Geoffrey Neale; Peter J Murray; Martine F Roussel; Brenda A Schulman
E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification.
Molecular cell 2009;33(4):483-95.
2009: Tamar Uziel; Fedor V Karginov; Suqing Xie; Joel Parker; Yong-Dong Wang; Amar Gajjar; Lin He; David Ellison; Richard J Gilbertson; Gregory Hannon; Martine F Roussel
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(8):2812-7.
2009: Olivier Ayrault; Frederique Zindy; Jerold E Rehg; Charles J Sherr; Martine F Roussel
Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.
Molecular cancer research : MCR 2009;7(1):33-40.
2008: Judith Souphron; M Brett Waddell; Amir Paydar; Zeynep Tokgöz-Gromley; Martine F Roussel; Brenda A Schulman
Structural dissection of a gating mechanism preventing misactivation of ubiquitin by NEDD8's E1.
Biochemistry 2008;47(34):8961-9.
2008: Haotian Zhao; Olivier Ayrault; Frederique Zindy; Jee-Hae Kim; Martine F Roussel
Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development.
Genes & development 2008;22(6):722-7.
2008: Rodrigo A. P. Martins; Frederique Zindy; Stacy L Donovan; Jiakun Zhang; Stan Pounds; Alice Wey; Paul Knoepfler; Robert N Eisenman; Martine F Roussel; Michael A Dyer
N-myc coordinates retinal growth with eye size during mouse development.
Genes & development 2008;22(2):179-93.
2007: Lisa M Nilsson; Ulrich B Keller; Chunying Yang; Jonas A Nilsson; John L Cleveland; Martine F Roussel
Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Oncogene 2007;26(20):2833-9.
2007: Olivier Ayrault; Frederique Zindy; Martine F Roussel
[TP53 and RB tumor suppressor pathways collaborate in retinoblastoma genesis].
Médecine sciences : M/S 2007;23(4):356-8.
2007: Frederique Zindy; Tamar Uziel; Olivier Ayrault; Christopher Calabrese; Marc Valentine; Jerold E Rehg; Richard J Gilbertson; Charles J Sherr; Martine F Roussel
Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
Cancer research 2007;67(6):2676-84.
2007: Heidi Laine; Angelika Doetzlhofer; Johanna Mantela; Jukka Ylikoski; Marikki Laiho; Martine F Roussel; Neil Segil; Ulla Pirvola
p19(Ink4d) and p21(Cip1) collaborate to maintain the postmitotic state of auditory hair cells, their codeletion leading to DNA damage and p53-mediated apoptosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(6):1434-44.
2006: Frederique Zindy; Paul Knoepfler; Suqing Xie; Charles J Sherr; Robert N Eisenman; Martine F Roussel
N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(31):11579-83.
2006: Richard Williams; Martine F Roussel; Charles J Sherr
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6688-93.
2006: Tamar Uziel; Frederique Zindy; Charles J Sherr; Martine F Roussel
The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.
Cell cycle (Georgetown, Tex.) 2006;5(4):363-5.
2006: Sara Gil-Perotin; Mireya Marin-Husstege; Jiadong Li; Mario Soriano-Navarro; Frederique Zindy; Martine F Roussel; Jose Manuel Garcia-Verdugo; Patrizia Casaccia-Bonnefil
Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(4):1107-16.
2005: Tamar Uziel; Frederique Zindy; Suqing Xie; youngsoo Lee; Antoine Forget; Susan M Magdaleno; Jerold E Rehg; Christopher Calabrese; David J Solecki; Charles G Eberhart; Sarah E Sherr; Sarah Plimmer; Steven C Clifford; Mary E Hatten; Peter J McKinnon; Richard J Gilbertson; Tom Curran; Charles J Sherr; Martine F Roussel
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.
Genes & development 2005;19(22):2656-67.
2005: Charles J Sherr; David Bertwistle; Willem den Besten; Mei-Ling Kuo; Masataka Sugimoto; Kenji Tago; Richard Williams; Frederique Zindy; Martine F Roussel
p53-Dependent and -independent functions of the Arf tumor suppressor.
Cold Spring Harbor symposia on quantitative biology 2005;70():129-37.
2004: David Bertwistle; Frederique Zindy; Charles J Sherr; Martine F Roussel
Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein.
Hybridoma and hybridomics 2004;23(5):293-300.
2004: Mei-Ling Kuo; Willem den Besten; David Bertwistle; Martine F Roussel; Charles J Sherr
N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Genes & development 2004;18(15):1862-74.
2004: Tomoya Yokota; Youichirou Matsuzaki; Kazuhiro Miyazawa; Frederique Zindy; Martine F Roussel; Toshiyuki Sakai
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Oncogene 2004;23(31):5340-9.
2003: Frederique Zindy; Richard Williams; Troy A Baudino; Jerold E Rehg; Stephen Xavier Skapek; John L Cleveland; Martine F Roussel; Charles J Sherr
Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15930-5.
2003: youngsoo Lee; Heather L Miller; Patricia Jensen; Roberto Hernan; Michele Connelly; Cynthia Wetmore; Frederique Zindy; Martine F Roussel; Tom Curran; Richard J Gilbertson; Peter J McKinnon
A molecular fingerprint for medulloblastoma.
Cancer research 2003;63(17):5428-37.
2003: Frederique Zindy; Lisa M Nilsson; Luc Nguyen; Cecile Meunier; Richard J Smeyne; Jerold E Rehg; Charles G Eberhart; Charles J Sherr; Martine F Roussel
Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.
Cancer research 2003;63(17):5420-7.
2003: Ping Chen; Frederique Zindy; Caroline Abdala; Feng Liu; Xiankui Li; Martine F Roussel; Neil Segil
Progressive hearing loss in mice lacking the cyclin-dependent kinase inhibitor Ink4d.
Nature cell biology 2003;5(5):422-6.
2003: Troy A Baudino; Kirsteen H Maclean; Jennifer Brennan; Evan Parganas; Chunying Yang; Aaron S. Aslanian; Jacqueline A Lees; Charles J Sherr; Martine F Roussel; John L Cleveland
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Molecular cell 2003;11(4):905-14.
2003: Mei-Ling Kuo; Eric J Duncavage; Rose Mathew; Willem den Besten; Deqing Pei; Deanna Naeve; Tadashi Yamamoto; Cheng Cheng; Charles J Sherr; Martine F Roussel
Arf induces p53-dependent and -independent antiproliferative genes.
Cancer research 2003;63(5):1046-53.
2003: Masataka Sugimoto; Mei-Ling Kuo; Martine F Roussel; Charles J Sherr
Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.
Molecular cell 2003;11(2):415-24.
2002: Martine F Roussel
p53: regular or super?
Cancer cell 2002;2(6):434-5.
2002: Justine J Cunningham; Edward M Levine; Frederique Zindy; Olga Goloubeva; Martine F Roussel; Richard J Smeyne
The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit.
Molecular and cellular neurosciences 2002;19(3):359-74.
2002: Jinjun Dang; Mei-Ling Kuo; Christine M Eischen; Lilia Stepanova; Charles J Sherr; Martine F Roussel
The RING domain of Mdm2 can inhibit cell proliferation.
Cancer research 2002;62(4):1222-30.
2001: Christine M Eischen; Martine F Roussel; Stanley J Korsmeyer; John L Cleveland
Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Molecular and cellular biology 2001;21(22):7653-62.
2001: DH Randle; Frederique Zindy; Charles J Sherr; Martine F Roussel
Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(17):9654-9.
2001: R Drissi; Frederique Zindy; Martine F Roussel; J L Cleveland
c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells.
The Journal of biological chemistry 2001;276(32):29994-30001.
2001: Justine J Cunningham; Martine F Roussel
Cyclin-dependent kinase inhibitors in the development of the central nervous system.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2001;12(8):387-96.
2001: Christine M Eischen; David D Woo; Martine F Roussel; John L Cleveland
Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
Molecular and cellular biology 2001;21(15):5063-70.
2001: Frederique Zindy; Willem den Besten; B Chen; Jerold E Rehg; E Latres; Mariano Barbacid; Jeffrey W Pollard; Charles J Sherr; Paula E Cohen; Martine F Roussel
Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
Molecular and cellular biology 2001;21(9):3244-55.
2000: Arjan Buijs; L van Rompaey; Anco C Molijn; James Davis; A C Vertegaal; M D Potter; C Adams; Sjozef van Baal; Ellen C Zwarthoff; Martine F Roussel; Gerard C Grosveld
The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Molecular and cellular biology 2000;20(24):9281-93.
2000: Jason D. Weber; John R Jeffers; Jerold E Rehg; DH Randle; G Lozano; Martine F Roussel; Charles J Sherr; Gerard P Zambetti
p53-independent functions of the p19(ARF) tumor suppressor.
Genes & development 2000;14(18):2358-65.
2000: Veronika Sexl; Roland P Piekorz; Richard Moriggl; J Rohrer; M P Brown; Kevin D Bunting; K Rothammer; Martine F Roussel; James N Ihle
Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.
Blood 2000;96(6):2277-83.
2000: Anja Groth; Jason D. Weber; Berthe M Willumsen; Charles J Sherr; Martine F Roussel
Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
The Journal of biological chemistry 2000;275(35):27473-80.
2000: K Inoue; R Wen; Jerold E Rehg; M Adachi; John L Cleveland; Martine F Roussel; Charles J Sherr
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Genes & development 2000;14(14):1797-809.
2000: Anne-Marie O'Farrell; D A Parry; Frederique Zindy; Martine F Roussel; Emma Lees; Kevin W Moore; Alice L-F Mui
Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4607-15.
2000: Jason D. Weber; Mei-Ling Kuo; Brian Bothner; Enrico L DiGiammarino; Richard W Kriwacki; Martine F Roussel; Charles J Sherr
Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Molecular and cellular biology 2000;20(7):2517-28.
2000: Frederique Zindy; Jan M A van Deursen; Gerard C Grosveld; Charles J Sherr; Martine F Roussel
INK4d-deficient mice are fertile despite testicular atrophy.
Molecular and cellular biology 2000;20(1):372-8.
1999: Frederique Zindy; Justine J Cunningham; Charles J Sherr; S Jogal; Richard J Smeyne; Martine F Roussel
Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(23):13462-7.
1999: Christine M Eischen; Jason D. Weber; Martine F Roussel; Charles J Sherr; John L Cleveland
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Genes & development 1999;13(20):2658-69.
1999: Sobha Jaishankar; J Zhang; Martine F Roussel; Suzanne J Baker
Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.
Oncogene 1999;18(40):5592-7.
1999: Martine F Roussel
The INK4 family of cell cycle inhibitors in cancer.
Oncogene 1999;18(38):5311-7.
1999: Jason D. Weber; Laura J Taylor; Martine F Roussel; Charles J Sherr; Dafna Bar-Sagi
Nucleolar Arf sequesters Mdm2 and activates p53.
Nature cell biology 1999;1(1):20-6.
1999: K Inoue; Martine F Roussel; Charles J Sherr
Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):3993-8.
1999: M Cheng; P Olivier; J Alan Diehl; M Fero; Martine F Roussel; J M Roberts; Charles J Sherr
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
The EMBO journal 1999;18(6):1571-83.
1999: M Cheng; D Wang; Martine F Roussel
Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1.
The Journal of biological chemistry 1999;274(10):6553-8.
1999: Veronika Sexl; J Alan Diehl; Charles J Sherr; RA Ashmun; D Beach; Martine F Roussel
A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2.
Oncogene 1999;18(3):573-82.
1998: J Alan Diehl; M Cheng; Martine F Roussel; Charles J Sherr
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Genes & development 1998;12(22):3499-511.
1998: R A Altura; T Inukai; RA Ashmun; G P Zambetti; Martine F Roussel; A Thomas Look
The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Blood 1998;92(4):1397-405.
1998: Elisa de Stanchina; Mila E McCurrach; Frederique Zindy; S Y Shieh; Gerardo Ferbeyre; Andrew V Samuelson; Carol Prives; Martine F Roussel; Charles J Sherr; Scott W Lowe
E1A signaling to p53 involves the p19(ARF) tumor suppressor.
Genes & development 1998;12(15):2434-42.
1998: Frederique Zindy; Christine M Eischen; DH Randle; T Kamijo; John L Cleveland; Charles J Sherr; Martine F Roussel
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
Genes & development 1998;12(15):2424-33.
1998: T Kamijo; Jason D. Weber; Gerard P Zambetti; Frederique Zindy; Martine F Roussel; Charles J Sherr
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(14):8292-7.
1998: M Cheng; Veronika Sexl; Charles J Sherr; Martine F Roussel
Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
Proceedings of the National Academy of Sciences of the United States of America 1998;95(3):1091-6.
1998: Martine F Roussel
Key effectors of signal transduction and G1 progression.
Advances in cancer research 1998;74():1-24.
1997: James Davis; C O Rock; M Cheng; J B Watson; RA Ashmun; HE Kirk; Robert J Kay; Martine F Roussel
Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase.
Molecular and cellular biology 1997;17(12):7398-406.
1997: T Kamijo; Frederique Zindy; Martine F Roussel; Dawn E Quelle; James R Downing; RA Ashmun; Gerard C Grosveld; Charles J Sherr
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
Cell 1997;91(5):649-59.
1997: Frederique Zindy; H Soares; K H Herzog; J Morgan; Charles J Sherr; Martine F Roussel
Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(11):1139-50.
1997: Frederique Zindy; Dawn E Quelle; Martine F Roussel; Charles J Sherr
Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Oncogene 1997;15(2):203-11.
1997: Martine F Roussel
Regulation of cell cycle entry and G1 progression by CSF-1.
Molecular reproduction and development 1997;46(1):11-8.
1996: Martine F Roussel; RA Ashmun; Charles J Sherr; Robert N Eisenman; Donald E Ayer
Inhibition of cell proliferation by the Mad1 transcriptional repressor.
Molecular and cellular biology 1996;16(6):2796-801.
1995: Martine F Roussel; A M Theodoras; M Pagano; Charles J Sherr
Rescue of defective mitogenic signaling by D-type cyclins.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(15):6837-41.
1995: H Hirai; Martine F Roussel; J Y Kato; RA Ashmun; Charles J Sherr
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Molecular and cellular biology 1995;15(5):2672-81.
1994: Martine F Roussel; James Davis; John L Cleveland; J Ghysdael; Scott W Hiebert
Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Oncogene 1994;9(2):405-15.
1994: S J Vallance; H M Lee; Martine F Roussel; Sheila A Shurtleff; J Y Kato; DK Strom; Charles J Sherr
Monoclonal antibodies to mammalian D-type G1 cyclins.
Hybridoma 1994;13(1):37-44.
1994: Charles J Sherr; J Kato; Dawn E Quelle; M Matsuoka; Martine F Roussel
D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response.
Cold Spring Harbor symposia on quantitative biology 1994;59():11-9.
1993: Dawn E Quelle; RA Ashmun; Sheila A Shurtleff; J Y Kato; D Bar-Sagi; Martine F Roussel; Charles J Sherr
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Genes & development 1993;7(8):1559-71.
1992: H Matsushime; Mark E Ewen; DK Strom; J Y Kato; S K Hanks; Martine F Roussel; Charles J Sherr
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
Cell 1992;71(2):323-34.
1992: Toshiya Inaba; H Matsushime; M Valentine; Martine F Roussel; Charles J Sherr; A Thomas Look
Genomic organization, chromosomal localization, and independent expression of human cyclin D genes.
Genomics 1992;13(3):565-74.
1992: T van Daalen Wetters; S A Hawkins; Martine F Roussel; Charles J Sherr
Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain.
The EMBO journal 1992;11(2):551-7.
1992: Charles J Sherr; H Matsushime; Martine F Roussel
Regulation of CYL/cyclin D genes by colony-stimulating factor 1.
Ciba Foundation symposium 1992;170():209-19; discussion 219-26.
1991: Martine F Roussel; John L Cleveland; Sheila A Shurtleff; Charles J Sherr
Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling.
Nature 1991;353(6342):361-3.
1991: H Matsushime; Martine F Roussel; K Matsushima; A Hishinuma; Charles J Sherr
Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1.
Blood 1991;78(3):616-23.
1991: H Matsushime; Martine F Roussel; RA Ashmun; Charles J Sherr
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.
Cell 1991;65(4):701-13.
1991: Charles J Sherr; G V Borzillo; J Kato; Sheila A Shurtleff; James R Downing; Martine F Roussel
Regulation of cell growth and differentiation by the colony-stimulating factor 1 receptor.
Seminars in hematology 1991;28(2):143-51.
1991: H Matsushime; Martine F Roussel; Charles J Sherr
Novel mammalian cyclins (CYL genes) expressed during G1.
Cold Spring Harbor symposia on quantitative biology 1991;56():69-74.
1990: Martine F Roussel; Sheila A Shurtleff; James R Downing; Charles J Sherr
A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(17):6738-42.
1990: Sheila A Shurtleff; James R Downing; C O Rock; S A Hawkins; Martine F Roussel; Charles J Sherr
Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase.
The EMBO journal 1990;9(8):2415-21.
1990: Martine F Roussel; Catherine transy; J Y Kato; Ellis L Reinherz; Charles J Sherr
Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor.
Molecular and cellular biology 1990;10(5):2407-12.
1990: M Ohtsuka; Martine F Roussel; Charles J Sherr; James R Downing
Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation.
Molecular and cellular biology 1990;10(4):1664-71.
1990: Martine F Roussel; J R Downing; Charles J Sherr
Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains.
Oncogene 1990;5(1):25-30.
1990: Charles J Sherr; J Y Kato; G Borzillo; James R Downing; Martine F Roussel
Signal-response coupling mediated by the transduced colony-stimulating factor-1 receptor and its oncogenic fms variants in naive cells.
Ciba Foundation symposium 1990;148():96-104; discussion 104-9.
1989: Martine F Roussel; Charles J Sherr
Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(20):7924-7.
1989: RA Ashmun; A Thomas Look; W M Roberts; Martine F Roussel; S Seremetis; M Ohtsuka; Charles J Sherr
Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells.
Blood 1989;73(3):827-37.
1988: Martine F Roussel; James R Downing; C W Rettenmier; Charles J Sherr
A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.
Cell 1988;55(6):979-88.
1988: W M Roberts; A Thomas Look; Martine F Roussel; Charles J Sherr
Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes.
Cell 1988;55(4):655-61.
1988: C W Rettenmier; Martine F Roussel
Differential processing of colony-stimulating factor 1 precursors encoded by two human cDNAs.
Molecular and cellular biology 1988;8(11):5026-34.
1988: Charles J Sherr; Martine F Roussel; C W Rettenmier
Colony-stimulating factor-1 receptor (c-fms).
Journal of cellular biochemistry 1988;38(3):179-87.
1988: Martine F Roussel; James R Downing; RA Ashmun; C W Rettenmier; Charles J Sherr
Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):5903-7.
1988: Martine F Roussel; C W Rettenmier; Charles J Sherr
Introduction of a human colony stimulating factor-1 gene into a mouse macrophage cell line induces CSF-1 independence but not tumorigenicity.
Blood 1988;71(5):1218-25.
1988: C W Rettenmier; Martine F Roussel; Charles J Sherr
The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
Journal of cell science. Supplement 1988;9():27-44.
1988: Charles J Sherr; C W Rettenmier; Martine F Roussel
Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor.
Cold Spring Harbor symposia on quantitative biology 1988;53 Pt 1():521-30.
1987: J M Heard; Martine F Roussel; C W Rettenmier; Charles J Sherr
Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene.
Cell 1987;51(4):663-73.
1987: J M Heard; Martine F Roussel; C W Rettenmier; Charles J Sherr
Synthesis, post-translational processing, and autocrine transforming activity of a carboxylterminal truncated form of colony stimulating factor-1.
Oncogene research 1987;1(4):423-40.
1987: C W Rettenmier; Martine F Roussel; RA Ashmun; P Ralph; K Price; Charles J Sherr
Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes.
Molecular and cellular biology 1987;7(7):2378-87.
1986: E F Wheeler; Martine F Roussel; A Hampe; M H Walker; V A Fried; A T Look; C W Rettenmier; Charles J Sherr
The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.
Journal of virology 1986;59(2):224-33.
1986: C W Rettenmier; Martine F Roussel; E F Wheeler; Charles J Sherr
Requirements for transformation by the fms oncogene product (CSF-1 receptor).
Princess Takamatsu symposia 1986;17():211-8.